These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23220449)

  • 1. Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence.
    Lock EA; Zhang J; Checkoway H
    Toxicol Appl Pharmacol; 2013 Feb; 266(3):345-55. PubMed ID: 23220449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease.
    De Miranda BR; Castro SL; Rocha EM; Bodle CR; Johnson KE; Greenamyre JT
    Neurobiol Dis; 2021 Jun; 153():105312. PubMed ID: 33636387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity.
    Gash DM; Rutland K; Hudson NL; Sullivan PG; Bing G; Cass WA; Pandya JD; Liu M; Choi DY; Hunter RL; Gerhardt GA; Smith CD; Slevin JT; Prince TS
    Ann Neurol; 2008 Feb; 63(2):184-92. PubMed ID: 18157908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity.
    Langley MR; Ghaisas S; Ay M; Luo J; Palanisamy BN; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Neurotoxicology; 2018 Jan; 64():240-255. PubMed ID: 28595911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.
    Ghosh A; Saminathan H; Kanthasamy A; Anantharam V; Jin H; Sondarva G; Harischandra DS; Qian Z; Rana A; Kanthasamy AG
    J Biol Chem; 2013 Jul; 288(30):21955-71. PubMed ID: 23754278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant α-synuclein mice.
    Keane PC; Hanson PS; Patterson L; Blain PG; Hepplewhite P; Khundakar AA; Judge SJ; Kahle PJ; LeBeau FEN; Morris CM
    Neurosci Lett; 2019 Oct; 711():134437. PubMed ID: 31422098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichloroethylene: Mechanistic, epidemiologic and other supporting evidence of carcinogenic hazard.
    Rusyn I; Chiu WA; Lash LH; Kromhout H; Hansen J; Guyton KZ
    Pharmacol Ther; 2014 Jan; 141(1):55-68. PubMed ID: 23973663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traumatic brain injury and trichloroethylene exposure interact and produce functional, histological, and mitochondrial deficits.
    Sauerbeck A; Hunter R; Bing G; Sullivan PG
    Exp Neurol; 2012 Mar; 234(1):85-94. PubMed ID: 22201550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats.
    Liu M; Choi DY; Hunter RL; Pandya JD; Cass WA; Sullivan PG; Kim HC; Gash DM; Bing G
    J Neurochem; 2010 Feb; 112(3):773-83. PubMed ID: 19922440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage.
    Franke SK; van Kesteren RE; Wubben JA; Hofman S; Paliukhovich I; van der Schors RC; van Nierop P; Smit AB; Philippens IH
    Neuroscience; 2016 Jan; 312():247-59. PubMed ID: 26431624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of Nrf2-ARE activator on dopaminergic neuronal loss in Parkinson disease model mice: Possible involvement of heme oxygenase-1.
    Inose Y; Izumi Y; Takada-Takatori Y; Akaike A; Koyama Y; Kaneko S; Kume T
    Neurosci Lett; 2020 Sep; 736():135268. PubMed ID: 32712353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian Poisons.
    Jeitner TM; Kalogiannis M; Krasnikov BF; Gomolin I; Peltier MR; Moran GR
    Toxicol Sci; 2016 Jun; 151(2):388-402. PubMed ID: 27026709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichloroethylene and Parkinson's Disease: Risk Assessment.
    Liu M; Shin EJ; Dang DK; Jin CH; Lee PH; Jeong JH; Park SJ; Kim YS; Xing B; Xin T; Bing G; Kim HC
    Mol Neurobiol; 2018 Jul; 55(7):6201-6214. PubMed ID: 29270919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichloroethylene and Parkinson disease.
    Zaheer F; Slevin JT
    Neurol Clin; 2011 Aug; 29(3):657-65. PubMed ID: 21803216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichloroethylene and parkinsonism: a human and experimental observation.
    Guehl D; Bezard E; Dovero S; Boraud T; Bioulac B; Gross C
    Eur J Neurol; 1999 Sep; 6(5):609-11. PubMed ID: 10457397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia.
    Bai L; Zhang X; Li X; Liu N; Lou F; Ma H; Luo X; Ren Y
    Mol Med Rep; 2015 Jul; 12(1):1002-8. PubMed ID: 25777539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.
    Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S
    Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal exposure to oxidative phosphorylation xenobiotics and late-onset Parkinson disease.
    Iglesias E; Pesini A; Garrido-Pérez N; Meade P; Bayona-Bafaluy MP; Montoya J; Ruiz-Pesini E
    Ageing Res Rev; 2018 Aug; 45():24-32. PubMed ID: 29689408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the nigrostriatal dopamine system after acute systemic PhIP exposure.
    Agim ZS; Cannon JR
    Toxicol Lett; 2018 May; 287():31-41. PubMed ID: 29378243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.